Industries > Pharma > Generic Drugs Market Forecast 2016-2026

Generic Drugs Market Forecast 2016-2026

Growth in Leading Regional and National Markets

PUBLISHED: 18 April 2016
PAGES: 306
PRODUCT CODE: PHA0109
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0109 Categories: ,

What can be expected from the Generic Drugs Market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.
 
Our 306-page report provides 175 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national generic drugs market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See detailed profiles or revenue forecasts for some of the leading regions in the generic drugs market
• US
• EU5
• Asia-Pacific
• Emerging markets

Generic Drugs Market Forecast 2016-2026

See revenue forecasts for the leading international markets
How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including:
• US
• Germany
• UK
• France
• Italy
• Spain
• China
• Japan
• India
• Brazil
• Russia
• Mexico
• South Korea
• Turkey

Leading companies and potential for market growth
Visiongain forecasts overall revenue for the Generic Drugs Market will reach $254.6bn in 2016. We predict a high revenue growth over the forecast period driven by an ageing population, healthcare cost saving strategies and rapid growth of emerging economies.

Our work analyses the key companies in the market. See Visiongain’s analysis of ten leading companies, including:
• Teva
• Novartis (Sandoz)
• Allergan
• Mylan
• Pfizer
• Abbott
• Sun Pharma
• Aspen
• Fresenius Kabi
• Sanofi

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Generic drugs revenue and share of total revenue
• Historic revenue (where available), analysis and discussion of company performance
• Analysis of major products currently on the market
• Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the generic drugs industry?
Our new report discusses issues and events affecting the generic drugs market. You will find discussions, including qualitative analyses:
• Highly fragmented and competitive market with significant variations in different geographic regions
• Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
• Future generic drug opportunities

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Generic Drugs Market Forecast 2016-2026: Growth in Leading Regional and National Markets report helps you
In summary, our 306-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Generic Drugs market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for major regional markets – US, EU5, Asia-Pacific, Emerging markets
• Revenue forecasts to 2026 for fourteen leading national markets – US, Germany, UK, France, Italy, Spain, China, Japan, India, Brazil, Russia, Mexico, South Korea and Turkey
• Assessment of leading companies – analysis of products, revenue (where available), mergers & acquisitions, and pipelines
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the generic drugs market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2016-2026


Latest Pharma news

Visiongain Publishes Pharmaceutical Spray Drying Market Report 2021-2031

The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.

25 October 2021

READ

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Categories